Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Erbitux Companion Test Approval Clears Path For Further Co-Development

This article was originally published in The Gray Sheet

Executive Summary

DakoCytomation expects reimbursement policies for ImClone's Erbitux colorectal cancer drug to guide adoption of companion diagnostic EGFR pharmDx
Advertisement

Related Content

ViroLogic Gets Molecular Cancer Test Platform With Aclara
ViroLogic Gets Molecular Cancer Test Platform With Aclara
Ventana Developing Companion Diagnostic For Novartis’ Gleevec Cancer Drug
Ventana Developing Companion Diagnostic For Novartis’ Gleevec Cancer Drug
Advertisement
UsernamePublicRestriction

Register

MT019975

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel